<--- Back to Details
First PageDocument Content
Emotion / Antidepressant / Organofluorides / Major depressive disorder / Food and Drug Administration / Suicide / Desvenlafaxine / Fluoxetine / Chemistry / Psychiatry / Selective serotonin reuptake inhibitors
Date: 2004-08-20 09:50:50
Emotion
Antidepressant
Organofluorides
Major depressive disorder
Food and Drug Administration
Suicide
Desvenlafaxine
Fluoxetine
Chemistry
Psychiatry
Selective serotonin reuptake inhibitors

M E M O R A N D U M DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 56,00 KB

Share Document on Facebook

Similar Documents

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

Microsoft WordDOCX

Microsoft WordDOCX

DocID: 1rnqZ - View Document

Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

DocID: 1rinj - View Document

SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1  SECTION 1

SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1

DocID: 1rdYu - View Document

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

DocID: 1rdbp - View Document